Multivitamins for people starting weight-loss injections
Part of Hormones & metabolism clinical trials.
This trial tests whether a multivitamin can help people on the weight-loss injection Tirzepatide maintain healthy vitamin levels. If you're using this injection and meet the other criteria, you may join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You started taking the weight-loss injection Tirzepatide and have been on a steady dose for at least 3 months.
- Before starting the injection, your body mass index (BMI) was 30 or higher, or 27 or higher with a weight-related health problem like type 2 diabetes, high blood pressure, or high cholesterol.
- You must be willing to stop taking any vitamins or supplements for 2 weeks before the study starts and then take the study multivitamin.
- You cannot be pregnant, plan to become pregnant, or be following a vegan diet.
- You have not had weight-loss surgery, do not have serious kidney or liver disease, and are not currently being treated for cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a multivitamin and a probiotic together can improve gut health for people who are currently taking a GLP-1 medication (like Ozempic or Wegovy). It aims to see if these supplements help with digestive issues that can come with these medications.
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
This trial tests an investigational injection called ZT003 to see if it is safe and how the body processes it. It is for healthy volunteers or those who are overweight or obese, to help understand how this treatment might work.
This study tests a new medicine called ALV-100 to see if it can help people who have already lost weight with a weight-loss injection or pill keep the weight off. You must be currently on a stable weight-loss medicine and have lost at least 10% of your body weight to join.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
Hear when a new Weight Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.